Singapore, Singapore

Oliver Simon

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 10.8

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: The Innovative Contributions of Oliver Simon in the Pharmaceutical Field

Introduction

Oliver Simon is a prominent inventor located in Singapore, SG, known for his impactful innovations in the pharmaceutical industry. With a total of four patents to his name, Simon has made significant strides in developing compounds aimed at treating various diseases, particularly those caused by viral and parasitic infections.

Latest Patents

Among his latest patents, Oliver Simon has developed N-substituted tetrahydrothienopyridine derivatives and their uses. This innovative compound, represented by a specific formula, has shown efficacy in treating diseases associated with viral infections. Furthermore, he has contributed to the field with another patent for compounds and compositions designed for the treatment of parasitic diseases. This invention offers compounds of a defined formula, including pharmaceutically acceptable salts, tautomers, or stereoisomers, and highlights the method of using these compounds to address diseases caused by parasites, such as malaria.

Career Highlights

Throughout his career, Oliver Simon has been associated with renowned companies such as Novartis AG and Irm LLC. His experience in these organizations has provided him with the foundation to develop groundbreaking innovations aimed at improving public health.

Collaborations

Simon has collaborated with a talented group of coworkers, including Wei Lin, Sandra Sim, and Bin Zou. These partnerships have facilitated the exchange of ideas and knowledge, contributing to the successful development of his patents.

Conclusion

In summary, Oliver Simon stands out as a notable inventor whose contributions to the pharmaceutical industry have the potential to significantly impact the treatment of viral and parasitic diseases. With his innovative patents and collaborative approach, Simon continues to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…